Miniatura

Fitxers

galatasb2017_2370.pdf (879.67 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2017-01-19

Llicència de publicació

cc by (c) Galatas et al., 2017
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/106529

Heterogeneity of G6PD deficiency prevalence in Mozambique: a school-based cross-sectional survey in three different regions

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1186/s12936-016-1674-y

Resum

Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked hereditary enzymatic abnormality that affects more than 400 million people worldwide. Most deficient individuals do not manifest any symptoms; however, several precipitant agents—such as fava intake, infections, or several drugs—may trigger acute haemolytic anaemia. Countries should be informed of the prevalence of this enzymatic anomaly within their borders, in order to make safe and appropriate national decisions regarding the use of potentially unsafe drugs for G6PD deficient individuals. Methods: A school-based cross-sectional survey was conducted in three districts in Mozambique, namely Manhiça, located in the south; Mocuba in the centre; and Pemba in the northern tip of the country. G6PD deficiency was evaluated using the CareStart™ diagnostic test, and enzyme activity levels were measured through fluorescence spectrophotometry in deficient individuals. Chi squared and ANOVA tests were used to assess prevalence and mean enzyme activity differences, and logistic regression was used to identify risk factors associated to the deficiency. Results: G6PD deficiency prevalence estimates were lowest in the northern city of Pemba (8.3%) and among Emakhuwas and Shimakondes, and higher in the centre and southern regions of the country (16.8 and 14.6%, respectively), particularly among Elomwes and Xichanganas. G6PD deficiency was significantly more prevalent among male students than females (OR = 1.4, 95% CI 1.0–1.8, p = 0.02), although enzyme activity levels were not different among deficient individuals from either gender group. Finally, median deficiency levels were found to be more severe among the deficient students from the north (0.7 U/gHg [0.2–0.7] p < 0.001) and south (0.7 U/gHg [0.5–2.5]), compared to those from the centre (1.4 U/gHg [0.6–2.1]). Conclusion: These findings suggest that Mozambique, as a historically high malaria-endemic country has considerable levels of G6PD deficiency, that vary significantly across the country. This should be considered when planning national strategies for the use of licensed drugs that may be associated to haemolysis among G6PD individuals, or prior to the performance of future trials using primaquine and other 8-aminoquinolines derivatives.

Matèries

Anèmia hemolítica, Moçambic

Matèries (anglès)

Hemolytic anemia, Mozambique

Citació

Col·leccions

Articles publicats en revistes (ISGlobal)

Citació

GALATAS, Beatriz, MABOTE, Lurdes, SIMONE, Wilson, MATAMBISSO, Gloria, NHAMUSSUA, Lidia, MAÑÚ PEREIRA, María del mar, MENÉNDEZ, Clara, SAUTE, Francisco, MACETE, Eusebio víctor, BASSAT ORELLANA, Quique, ALONSO, Pedro, AIDE, Pedro carlos paulino. Heterogeneity of G6PD deficiency prevalence in Mozambique: a
                school-based cross-sectional survey in three different regions. _Malaria Journal_. 2017. Vol. 16, núm. 36. [consulta: 14 de gener de 2026]. ISSN: 1475-2875. [Disponible a: https://hdl.handle.net/2445/106529]

Exportar metadades

JSON - METS

Compartir registre